---
figid: PMC4008642__nihms572820f1
figtitle: 'Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating
  Oxidative Phosphorylation'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4008642
filename: nihms572820f1.jpg
figlink: /pmc/articles/PMC4008642/figure/F1/
number: F1
caption: Growth factor mediated activation (EGF) of a receptor tyrosine kinase (EGFR)
  leads to downstream pathway signaling along the RAS-RAF-MEK-MAPK and PI3K-AKT-mTOR
  pathways. Key convergence points are MAPK mediated suppression of LKB1/AMPK energy
  sensing, and AKT activated translocation of the glucose transporter GLUT4 to the
  plasma membrane leading to augmented glucose import for anabolic (nucleotides, lipids,
  and amino acids) in addition to catabolism towards ATP regeneration in the mitochondria
  utilizing the proton gradient. Furthermore, MAPK stabilizes and mTOR increases translation
  of HIF1α, triggering the transcriptional function with effects on reducing pyruvate
  decarboxylation/oxidation to acetyl-CoA (Ac-CoA) destined for use in the TCA cycle.
  In melanoma cells, HIF1α activity reduces expression of MITF-PGC1α levels and thereby
  causes effects on reducing mitochondrial bioactivity (OXPHOS, ROS protection) in
  addition to differentiation associated cascades. Frequently mutant components (and
  pathways) in human cancers are indicted in red. Inhibitors of indicated pathway
  components are indicated in blue.
papertitle: 'Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating
  Oxidative Phosphorylation.'
reftext: Rizwan Haq, et al. Clin Cancer Res. ;20(9):2257-2263.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9645653
figid_alias: PMC4008642__F1
figtype: Figure
redirect_from: /figures/PMC4008642__F1
ndex: d113dff8-debc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4008642__nihms572820f1.html
  '@type': Dataset
  description: Growth factor mediated activation (EGF) of a receptor tyrosine kinase
    (EGFR) leads to downstream pathway signaling along the RAS-RAF-MEK-MAPK and PI3K-AKT-mTOR
    pathways. Key convergence points are MAPK mediated suppression of LKB1/AMPK energy
    sensing, and AKT activated translocation of the glucose transporter GLUT4 to the
    plasma membrane leading to augmented glucose import for anabolic (nucleotides,
    lipids, and amino acids) in addition to catabolism towards ATP regeneration in
    the mitochondria utilizing the proton gradient. Furthermore, MAPK stabilizes and
    mTOR increases translation of HIF1α, triggering the transcriptional function with
    effects on reducing pyruvate decarboxylation/oxidation to acetyl-CoA (Ac-CoA)
    destined for use in the TCA cycle. In melanoma cells, HIF1α activity reduces expression
    of MITF-PGC1α levels and thereby causes effects on reducing mitochondrial bioactivity
    (OXPHOS, ROS protection) in addition to differentiation associated cascades. Frequently
    mutant components (and pathways) in human cancers are indicted in red. Inhibitors
    of indicated pathway components are indicated in blue.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Tie
  - Ras85D
  - InR
  - ras
  - Ras64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - adp
  - Amph
  - ATPsynbeta
  - Atpalpha
  - Akt
  - Lkb1
  - Dsor1
  - Mtk
  - SNF4Agamma
  - AMPKalpha
  - Mtor
  - Tor
  - MKP-4
  - p38b
  - rl
  - Pdk1
  - dec
  - Mitf
  - EGF
  - EGFR
  - SLC2A4
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - BRAF
  - WDTC1
  - APRT
  - MFAP1
  - ATP8A2
  - AKT1
  - AKT2
  - AKT3
  - STK11
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PDK1
  - PDPK1
  - BHLHE40
  - DELEC1
  - MITF
  - AIP
  - AURKAIP1
  - Glucose
  - glucose
  - metformin
  - phenformin
  - pyruvate
  - 2,4-DNP
  - lactate
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
---
